Patient Guide: Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 11 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06101329
Status: ACTIVE_NOT_RECRUITING
Condition: Pre-Exposure Prophylaxis of HIV Infection
Phase: PHASE2

Where You Can Participate

This study is available at 11 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • San Diego, California
  • • Washington D.C., District of Columbia
  • • And 8 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) - Join Clinical Trial NCTNCT06101329

How to Join This Clinical Trial - NCTNCT06101329

Learn how to participate in this PHASE2 trial studying an investigational therapy for Pre-Exposure Prophylaxis of HIV Infection. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Pre-Exposure Prophylaxis of HIV Infection. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Pre-Exposure Prophylaxis of HIV Infection
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06101329 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 11 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35222 - United States

Status: Contact for availability

Clinical Research Site

San Diego, California 92103 - United States

Status: Contact for availability

Clinical Research Site

Washington D.C., District of Columbia 20037 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30303 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: Contact for availability

Clinical Research Site

Newark, New Jersey 07103 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10010 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10027 - United States

Status: Contact for availability

Clinical Research Site

The Bronx, New York 10451 - United States

Status: Contact for availability

Clinical Research Site

Chapel Hill, North Carolina 27599 - United States

Status: Contact for availability

And 1 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Pre-Exposure Prophylaxis of HIV Infection:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships